ORMP
ORAMED PHARMACEUTICALS INC.
+0.09 (+1.95%)4.71USD88.7K成交股數196M市值1.1本益比(近四季)98.0股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | 2.0M | – | – | – | – | – | 674K | 666K |
| 營業成本 | – | – | – | – | 2.0M | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | 13K | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | 0.7% | – | – | – | – | – | – | – |
| 研發費用 | – | 1.6M | 1.2M | 1.0M | 2.2M | 1.5M | 2.2M | 1.4M | 1.2M | 957K | 1.8M | 4.4M |
| 銷售管理費用 | 2.8M | 2.1M | 1.3M | 1.5M | 2.3M | 2.1M | 847K | 1.7M | 1.8M | 2.6M | 2.5M | 1.3M |
| 營業利益 | −2.8M-39% | −3.7M+2% | −2.4M-21% | −2.5M-21% | −4.5M+52% | −3.6M+24% | −3.1M-19% | −3.1M-40% | −3.0M | −2.9M | −3.8M | −5.2M |
| 營業利益率 | – | – | – | – | -225.0% | – | – | – | – | – | -562.5% | -782.0% |
| 稅後淨利 | 78.2M-1123% | 38.3M+333% | 48.4M-347% | 13.3M+44% | −7.6M-598% | 8.9M-375% | −19.6M+1543% | 9.2M-371% | 1.5M | −3.2M | −1.2M | −3.4M |
| 淨利率 | – | – | – | – | -382.1% | – | – | – | – | – | -177.2% | -509.8% |
| 稀釋 EPS | 1.84-1068% | 0.91-450% | 1.13-335% | 0.31+41% | -0.19-575% | -0.26+225% | -0.48+1500% | 0.22-375% | 0.04 | -0.08 | -0.03 | -0.08 |
| 稀釋股數 | 42.5M | 42.0M | 42.8M | 42.6M | 41.2M | 40.9M | 40.9M | 41.6M | 41.6M | 40.4M | 40.2M | 40.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 15.2M | 13.2M | 52.2M | 15.8M | 74.5M | 54.4M | 42.1M | 84.8M | 18.6M | 5.5M | 6.8M | 24.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 370M | 269M | 220M | 162M | 148M | 155M | 165M | 184M | 204M | 231M | 156M | 160M |
| 有息負債 | – | – | – | – | – | – | – | – | – | 74.6M | – | – |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 317M | 238M | 203M | 155M | 141M | 146M | 156M | 177M | 167M | 149M | 152M | 151M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | −69.1M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.9M | – | – | −3.5M+138% | – | – | – | −1.5M | – | – | −5.5M |
| 資本支出 | – | 5K | – | – | 3K | – | – | – | 2K | – | – | 199K |
| 自由現金流 | – | −2.9M | – | – | −3.5M+138% | – | – | – | −1.5M | – | – | −5.7M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | 10.4M | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | -176.1% | – | – | – | – | – | – | -863.1% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.0M | – | 75K | 3.8% | 1.50 | −9.2M |
| FY2024 | – | – | −16K | –% | -0.48 | −8.4M |
| FY2023 | 1.3M | -50.4% | 5K | 0.4% | 0.14 | −10.5M |
| FY2022 | 2.7M | 0.0% | −36.6M | -1,352.6% | -0.94 | −28.4M |
| FY2021 | 2.7M | -0.3% | −23.0M | -850.5% | 0.78 | −21.6M |
| FY2020 | 2.7M | +0.3% | −11.5M | -424.8% | 0.56 | −12.5M |
| FY2019 | 2.7M | – | −14.4M | -531.1% | 0.82 | −13.0M |